Macrophage metalloelastase (MMP12) regulates adipose tissue expansion, insulin sensitivity, and expression of inducible nitric oxide synthase. 2014

Jung-Ting Lee, and Nathalie Pamir, and Ning-Chun Liu, and Elizabeth A Kirk, and Michelle M Averill, and Lev Becker, and Ilona Larson, and Derek K Hagman, and Karen E Foster-Schubert, and Brian van Yserloo, and Karin E Bornfeldt, and Renee C LeBoeuf, and Mario Kratz, and Jay W Heinecke
Departments of Medicine (J.-T.L., N.P., N.-C.L., M.M.A., L.B., K.E.F.-S., B.V.Y., K.E.B., R.C.L., M.K., J.W.H.), Pathology (K.E.B.), and Epidemiology (E.A.K., M.K.), University of Washington, Seattle, Washington 98105; and Fred Hutchinson Cancer Research Center (D.K.H., M.K.), Public Health Sciences, Seattle, Washington 98103.

Macrophage metalloelastase, a matrix metallopeptidase (MMP12) predominantly expressed by mature tissue macrophages, is implicated in pathological processes. However, physiological functions for MMP12 have not been described. Because mRNA levels for the enzyme increase markedly in adipose tissue of obese mice, we investigated the role of MMP12 in adipose tissue expansion and insulin resistance. In humans, MMP12 expression correlated positively and significantly with insulin resistance, TNF-α expression, and the number of CD14(+)CD206(+) macrophages in adipose tissue. MMP12 was the most abundant matrix metallopeptidase detected by proteomic analysis of conditioned medium of M2 macrophages and dendritic cells. In contrast, it was detected only at low levels in bone marrow derived macrophages and M1 macrophages. When mice received a high-fat diet, adipose tissue mass increased and CD11b(+)F4/80(+)CD11c(-) macrophages accumulated to a greater extent in MMP12-deficient (Mmp12(-/-)) mice than in wild-type mice (Mmp12(+/+)). Despite being markedly more obese, fat-fed Mmp12(-/-) mice were more insulin sensitive than fat-fed Mmp12(+/+) mice. Expression of inducible nitric oxide synthase (Nos2) by Mmp12(-/-) macrophages was significantly impaired both in vivo and in vitro, suggesting that MMP12 might mediate nitric oxide production during inflammation. We propose that MMP12 acts as a double-edged sword by promoting insulin resistance while combatting adipose tissue expansion.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008820 Mice, Obese Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid. Hyperglycemic Mice,Obese Mice,Mouse, Hyperglycemic,Mouse, Obese,Hyperglycemic Mouse,Mice, Hyperglycemic,Obese Mouse
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Jung-Ting Lee, and Nathalie Pamir, and Ning-Chun Liu, and Elizabeth A Kirk, and Michelle M Averill, and Lev Becker, and Ilona Larson, and Derek K Hagman, and Karen E Foster-Schubert, and Brian van Yserloo, and Karin E Bornfeldt, and Renee C LeBoeuf, and Mario Kratz, and Jay W Heinecke
January 2015, Immunobiology,
Jung-Ting Lee, and Nathalie Pamir, and Ning-Chun Liu, and Elizabeth A Kirk, and Michelle M Averill, and Lev Becker, and Ilona Larson, and Derek K Hagman, and Karen E Foster-Schubert, and Brian van Yserloo, and Karin E Bornfeldt, and Renee C LeBoeuf, and Mario Kratz, and Jay W Heinecke
November 1997, Archives of surgery (Chicago, Ill. : 1960),
Jung-Ting Lee, and Nathalie Pamir, and Ning-Chun Liu, and Elizabeth A Kirk, and Michelle M Averill, and Lev Becker, and Ilona Larson, and Derek K Hagman, and Karen E Foster-Schubert, and Brian van Yserloo, and Karin E Bornfeldt, and Renee C LeBoeuf, and Mario Kratz, and Jay W Heinecke
May 2001, Current protocols in toxicology,
Jung-Ting Lee, and Nathalie Pamir, and Ning-Chun Liu, and Elizabeth A Kirk, and Michelle M Averill, and Lev Becker, and Ilona Larson, and Derek K Hagman, and Karen E Foster-Schubert, and Brian van Yserloo, and Karin E Bornfeldt, and Renee C LeBoeuf, and Mario Kratz, and Jay W Heinecke
January 1996, The Journal of biological chemistry,
Jung-Ting Lee, and Nathalie Pamir, and Ning-Chun Liu, and Elizabeth A Kirk, and Michelle M Averill, and Lev Becker, and Ilona Larson, and Derek K Hagman, and Karen E Foster-Schubert, and Brian van Yserloo, and Karin E Bornfeldt, and Renee C LeBoeuf, and Mario Kratz, and Jay W Heinecke
July 2007, The Journal of clinical endocrinology and metabolism,
Jung-Ting Lee, and Nathalie Pamir, and Ning-Chun Liu, and Elizabeth A Kirk, and Michelle M Averill, and Lev Becker, and Ilona Larson, and Derek K Hagman, and Karen E Foster-Schubert, and Brian van Yserloo, and Karin E Bornfeldt, and Renee C LeBoeuf, and Mario Kratz, and Jay W Heinecke
December 1997, Journal of immunology (Baltimore, Md. : 1950),
Jung-Ting Lee, and Nathalie Pamir, and Ning-Chun Liu, and Elizabeth A Kirk, and Michelle M Averill, and Lev Becker, and Ilona Larson, and Derek K Hagman, and Karen E Foster-Schubert, and Brian van Yserloo, and Karin E Bornfeldt, and Renee C LeBoeuf, and Mario Kratz, and Jay W Heinecke
September 2003, Cell and tissue research,
Jung-Ting Lee, and Nathalie Pamir, and Ning-Chun Liu, and Elizabeth A Kirk, and Michelle M Averill, and Lev Becker, and Ilona Larson, and Derek K Hagman, and Karen E Foster-Schubert, and Brian van Yserloo, and Karin E Bornfeldt, and Renee C LeBoeuf, and Mario Kratz, and Jay W Heinecke
March 2001, Journal of vascular surgery,
Jung-Ting Lee, and Nathalie Pamir, and Ning-Chun Liu, and Elizabeth A Kirk, and Michelle M Averill, and Lev Becker, and Ilona Larson, and Derek K Hagman, and Karen E Foster-Schubert, and Brian van Yserloo, and Karin E Bornfeldt, and Renee C LeBoeuf, and Mario Kratz, and Jay W Heinecke
June 2005, Molecular pharmacology,
Jung-Ting Lee, and Nathalie Pamir, and Ning-Chun Liu, and Elizabeth A Kirk, and Michelle M Averill, and Lev Becker, and Ilona Larson, and Derek K Hagman, and Karen E Foster-Schubert, and Brian van Yserloo, and Karin E Bornfeldt, and Renee C LeBoeuf, and Mario Kratz, and Jay W Heinecke
January 2004, The Journal of laboratory and clinical medicine,
Copied contents to your clipboard!